Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Legislation & Advocacy

Why the REF?

Leslie Crofford, MD  |  

I am delighted to use the occasion of this inaugural REF president’s column to share a vision of the future and describe the exciting developments that will allow us to meet the challenges ahead. Although most of you know that the ACR is associated with a foundation, I find that many of our members wonder what the REF does that is different from the mission and activities of the ACR and the ARHP. In the simplest terms, the ACR and the ARHP are engaged in improving the quality of our professional lives as rheumatologists and rheumatology health professionals, while the core mission of the REF is to ensure the future of our specialty.

Where Do RheumPAC Donations Go?

  |  

RheumPAC has been a standing committee of the ACR since 2007. The PAC was established to increase the ACR’s presence in Washington, D.C., and is charged with managing the contributions to congressional campaigns, as well as soliciting the membership for funds to increase the purse for these contributions.

RheumPAC: One Year, One Contribution, One Opportunity

  |  

Responders to the recent ACR membership survey emphasized the importance of political advocacy for their practices and institutions. RheumPAC, the ACR’s political action committee, was created in February 2007 to focus on the legislative issues affecting the rheumatology community.

Fredrica Smith, MD, Appointed to Practicing Physicians Advisory Council (PPAC)

  |  

Fredrica Smith, MD, a rheumatologist in Los Alamos, N.M., was recently invited to become a part of the Practicing Physicians Advisory Council (PPAC), a congressionally mandated council that advises the secretary of the Department of Health and Human Services and the administrator of CMS on proposed changes in regulations.

American College of Rheumatology (ACR) on Capitol Hill

  |  

“By tomorrow night, there will be so many more people on Capitol Hill who know—and are sensitive to—rheumatology and the issues that impact you and your patients. There is no substitute for what you are doing,” says Martha M. Kendrick, a partner at Patton Boggs, LLP, the ACR’s lobbying firm. This is what she told the physician, health professional, and patient participants of the ACR’s 2008 “Advocates for Arthritis” advocacy event—termed a fly-in—before they took their personal stories to the lawmakers on Capitol Hill.

Advocacy and More

David A. Fox, MD  |  

A week in the life of the ACR

Eye on the Election

  |  

Over the past two years, we have heard presidential candidates touting their messages to voters. Each candidate has crafted messages they believe will appeal to voters, and as campaigns continue to accelerate, these messages will saturate the radio, television, and the reading materials of the American public.

Research Funded by Within Our Reach Highlighted

  |  

Five Within Our Reach science investigators provided overviews and updates of their RA research projects to the newly formed Within Our Reach advisory board at its inaugural meeting, held November 8, 2007.

Increase NIH Funding, Participate in Advocates for Arthritis

  |  

The ACR consistently urges Congress to support issues relating to rheumatologists, rheumatology health professionals, and patients. The primary advocacy goals are: supporting of the “Arthritis Prevention, Control, and Cure Act of 2007” (H.R.1283/S.626) and the “Access to Medicare Imaging Act of 2007” (H.R.1293/S.1338), finding a permanent solution to the Medicare reimbursement issue, and increasing funding for the National Institutes of Health (NIH)—including the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Institute of Allergy and Infectious Diseases—and other agencies, such as the Centers for Disease Control and Prevention, the Agency for Healthcare Research and Quality, the Department of Veterans Affairs’ Medical and Prosthetic Research Program.